Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum
AssigneeWashington Research Foundation
InventorDavid R. Eyre
Life of this patent
Estimating the term…
Abstract
An enzyme linked immunosorbent assay (ELISA) kit for the quantification of degradation products of carboxy-terminal telopeptides of type I collagen in a human serum sample, including an antibody that is characterized by binding to at least one peptide derived from the carboxy-terminal telopeptide domain of type I collagen and isolatable from a urine sample of a patient with active Paget's disease.
Claims1
An enzyme linked immunosorbent assay (ELISA) kit for the quantification of degradation products of carboxy-terminal telopeptides of type I collagen in a human serum sample, comprising an antibody that is characterized by binding to at least one peptide derived from the carboxy-terminal telopeptide domain of type I collagen and having a 3-hydroxypyridinium cross-link, wherein the peptide is isolatable from a urine sample of a patient with active Paget's disease by a process which comprises the following steps:
- dialyzing the urine sample in reduced porosity dialysis tubing (>3,500), and freeze-drying the non-diffusate;
- chromatographing the dried material on a Bio-Gel P2 column in 10% acetic acid at room temperature, identifying a region of effluent that contains 3-hydroxypyridinium cross-linked peptides by measuring the fluorescence of collected fractions at 297 nm excitation/395 nm emission, and freeze-drying the pooled fluorescent fractions;
- chromatographing the dried material on a Bio-Gel P-4 column eluted at 10% acetic acid, identifying two overlapping fraction pools by fluorescence of the eluant as measured above, and freeze-drying the earlier fraction pool;
- chromatographing the dried material by ion-exchange HPLC on a TSK DEAE-5-PW column eluted with a gradient of NaCl (0-0.2M) in 0.02M Tris-HCl, pH 7.5 containing 10% (v/v) acetonitrile, identifying carboxy-terminal type I collagen telopeptide peaks that elute between 0.08M and 0.15M NaCl by fluorescence as measured above, and freeze-drying each peak;
- chromatographing each dried peak on a C-18 reverse phase HPLC column eluted with a gradient (0-10%) of a acetonitrile:n-propanol (3.1 v/v) in 0.01M trifluoroacetic acid to isolate the individual peptides;
- selecting isolated peptides that contain a 3-hydroxypyridinium cross-link derived from the carboxy-terminal telopeptide domain of type I collagen;
- and
- confirming that the antibody binds to at least one of the selected isolated peptides.
Dependencies are inferred from the claim text.